The Role of MicroRNAs in Arrhythmogenic Cardiomyopathy: Biomarkers or Innocent Bystanders of Disease Progression?
Open Access
- 3 September 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (17) , 6434
Abstract
Arrhythmogenic cardiomyopathy (AC) is an inherited cardiac disease characterized by a progressive fibro-fatty replacement of the working myocardium and by life-threatening arrhythmias and risk of sudden cardiac death. Pathogenic variants are identified in nearly 50% of affected patients mostly in genes encoding for desmosomal proteins. AC incomplete penetrance and phenotypic variability advocate that other factors than genetics may modulate the disease, such as microRNAs (miRNAs). MiRNAs are small noncoding RNAs with a primary role in gene expression regulation and network of cellular processes. The implication of miRNAs in AC pathogenesis and their role as biomarkers for early disease detection or differential diagnosis has been the objective of multiple studies employing diverse designs and methodologies to detect miRNAs and measure their expression levels. Here we summarize experiments, evidence, and flaws of the different studies and hitherto knowledge of the implication of miRNAs in AC pathogenesis and diagnosis.Keywords
Funding Information
- Registry for (Cardio-cerebro-vascular Pathology, Veneto Region, Venice, Italy)
- Ministero della Salute (RF-2013-02356762, RF-2014-00000394)
- Regione del Veneto (933/2015)
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2015ZLNETW_001, PRIN20173ZWACS)
- University of Padua Research Grants (CPDA144300, BIRD192170)
- Fondazione Cassa di Risparmio di Padova e Rovigo (2017 SHoCD Cariparo Foundation)
This publication has 76 references indexed in Scilit:
- Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathyHeart Rhythm, 2012
- Nuclear Plakoglobin Is Essential for Differentiation of Cardiac Progenitor Cells to Adipocytes in Arrhythmogenic Right Ventricular CardiomyopathyCirculation Research, 2011
- Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap SyndromesCirculation, 2011
- Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force CriteriaEuropean Heart Journal, 2010
- Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular CardiomyopathyCirculation Research, 2009
- Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 GeneThe American Journal of Human Genetics, 2008
- Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated with Mutations in the Desmosomal Gene Desmocollin-2The American Journal of Human Genetics, 2006
- Suppression of canonical Wnt/ -catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathyJournal of Clinical Investigation, 2006
- Right Ventricular Cardiomyopathy and Sudden Death in Young PeopleNew England Journal of Medicine, 1988
- Right ventricular dysplasia: a report of 24 adult cases.Circulation, 1982